Filing Details

Accession Number:
0001415889-24-026102
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-05 15:04:53
Reporting Period:
2024-11-01
Accepted Time:
2024-11-05 15:04:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534133 Calcimedica Inc. CALC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267959 A Fred Middleton C/O Calcimedica, Inc.
505 Coast Blvd. S. #307
La Jolla CA 92037
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-01 20,000 $3.75 31,714 No 4 P Direct
Common Stock Acquisiton 2024-11-01 86,867 $3.75 814,300 No 4 P Indirect By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock Acquisiton 2024-11-01 877 $3.75 22,479 No 4 P Indirect By Sanderling Ventures Management VI
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Sanderling Venture Partners VI Co-Investment Fund, L.P.
No 4 P Indirect By Sanderling Ventures Management VI
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 946,744 Indirect By Sanderling Venture Partners VI, LP
Common Stock 7,456 Indirect By Sanderling VI Beteligungs GmbH & Co KG
Common Stock 8,884 Indirect By Sanderling VI Limited Partnership
Common Stock 435,148 Indirect By Sanderling Ventures VII, L.P.
Common Stock 114,260 Indirect By Sanderling Ventures VII (Canada), L.P.
Common Stock 27,609 Indirect By Sanderling Ventures VII Annex Fund, L.P.
Common Stock 30,292 Indirect By Sanderling Ventures Management VII
Common Stock 8,176 Indirect By Golden Triangle Ventures, LLC
Footnotes
  1. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  2. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  3. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  4. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  5. The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.